avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hes1 | mm10_v2_chr16_+_30065333_30065351 | 0.22 | 2.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_12026237 Show fit | 12.74 |
ENSMUST00000150972.1
|
growth factor receptor bound protein 10 |
|
chr11_-_12026732 Show fit | 11.43 |
ENSMUST00000143915.1
|
growth factor receptor bound protein 10 |
|
chr14_-_79301623 Show fit | 8.53 |
ENSMUST00000022595.7
|
regulator of cell cycle |
|
chr17_-_26199008 Show fit | 5.69 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
protein disulfide isomerase associated 2 |
|
chr8_+_23139064 Show fit | 4.48 |
ENSMUST00000033947.8
|
ankyrin 1, erythroid |
|
chr10_+_75571522 Show fit | 4.40 |
ENSMUST00000143226.1
ENSMUST00000124259.1 |
gamma-glutamyltransferase 1 |
|
chr19_-_24555819 Show fit | 4.40 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
|
chr15_+_89322969 Show fit | 3.21 |
ENSMUST00000066991.5
|
adrenomedullin 2 |
|
chr11_+_95010277 Show fit | 2.99 |
ENSMUST00000124735.1
|
sterile alpha motif domain containing 14 |
|
chr8_+_23139030 Show fit | 2.91 |
ENSMUST00000121075.1
|
ankyrin 1, erythroid |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 24.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.8 | 8.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 7.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 5.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.5 | 4.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.9 | 4.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 3.0 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.5 | 2.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 2.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 2.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 4.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 4.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 3.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 2.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 2.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 2.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 2.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 24.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 8.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 7.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 5.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 4.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.1 | 4.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 3.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 3.2 | GO:0005179 | hormone activity(GO:0005179) |
1.0 | 3.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 25.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 4.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 24.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 7.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |